Quarterly report pursuant to Section 13 or 15(d)

DEBT

v3.2.0.727
DEBT
6 Months Ended
Jun. 30, 2015
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]
7.
Debt
 
Revolving Line of Credit — The Company has an agreement with TD Bank for a revolving line of credit maturing on November 30, 2015 for up to $3 million. The line of credit has a variable rate of interest per annum at the Wall Street Journal prime rate plus 1% (4.25% as of June 30, 2015 and December 31, 2014). The line of credit is collateralized by all of the Company’s assets and is guaranteed by the CEO of the Company. The outstanding balance as of June 30, 2015 and December 31, 2014 was $3,000,000 and $1,215,000, respectively. The Company is prohibited from paying any dividends without the prior written consent of TD Bank.
 
Maturities of notes payable as of June 30, 2015 are as follows:
 
 
 
Vehicle
 
 
 
 
 
 
 
Years ending
 
Financing
 
Metro
 
Loan from
 
 
 
December 31
 
Notes
 
Medical
 
CEO
 
Total
 
2015 (Six months)
 
$
11,240
 
$
106,817
 
$
-
 
$
118,057
 
2016
 
 
23,718
 
 
-
 
 
470,089
 
 
493,807
 
2017
 
 
23,550
 
 
-
 
 
-
 
 
23,550
 
Thereafter
 
 
28,975
 
 
-
 
 
-
 
 
28,975
 
Total
 
$
87,483
 
$
106,817
 
$
470,089
 
$
664,389